- 专利标题: Inhibitors of β-hydroxylase for treatment of cancer
-
申请号: US16131275申请日: 2018-09-14
-
公开(公告)号: US10351555B2公开(公告)日: 2019-07-16
- 发明人: Mark Jon Olsen , John Michael Thomas
- 申请人: Midwestern University
- 申请人地址: US IL Downers Grove
- 专利权人: Midwestern University
- 当前专利权人: Midwestern University
- 当前专利权人地址: US IL Downers Grove
- 代理机构: Reed Smith LLP
- 主分类号: C07D307/26
- IPC分类号: C07D307/26 ; C07D307/32 ; C07D307/66 ; C07D405/04 ; C07D405/12 ; C07D409/04 ; C07D417/04 ; C12Q1/26 ; A61P35/00
摘要:
The present invention relates to compounds which modulate (e.g., inhibit) the activity of beta-hydrolase (e.g., ASPH), including novel 2-aryl-5-amino-3(2H)-furanone and 2-heteroaryl-5-amino-3(2H)-furanone compounds, pharmaceutical compositions thereof, methods for their synthesis, and methods of using these compounds to modulate the activity of ASPH in an a cell-free sample, a cell-based assay, and in a subject. Other aspects of the invention relate to use of the compounds disclosed herein to ameliorate or treat cell proliferation disorders.
公开/授权文献
- US20190002453A1 INHIBITORS OF BETA-HYDROXYLASE FOR TREATMENT OF CANCER 公开/授权日:2019-01-03